Advisor OS LLC Sells 71 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Advisor OS LLC trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 6.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,050 shares of the company’s stock after selling 71 shares during the period. Advisor OS LLC’s holdings in HCA Healthcare were worth $315,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of HCA. Private Advisor Group LLC boosted its holdings in HCA Healthcare by 2.5% in the 3rd quarter. Private Advisor Group LLC now owns 3,382 shares of the company’s stock valued at $1,374,000 after purchasing an additional 84 shares during the period. J.W. Cole Advisors Inc. lifted its holdings in shares of HCA Healthcare by 7.3% during the 3rd quarter. J.W. Cole Advisors Inc. now owns 1,045 shares of the company’s stock worth $425,000 after acquiring an additional 71 shares during the last quarter. Patriot Financial Group Insurance Agency LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter worth $219,000. Oak Harvest Investment Services bought a new stake in shares of HCA Healthcare during the 3rd quarter worth $2,875,000. Finally, Meitav Investment House Ltd. bought a new stake in shares of HCA Healthcare during the 3rd quarter worth $1,166,000. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

HCA has been the subject of several recent research reports. Truist Financial lowered their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Bank of America lowered their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. Barclays lowered their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. Finally, Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $320.55 on Friday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company’s 50-day moving average is $315.11 and its 200 day moving average is $349.91. The stock has a market capitalization of $79.60 billion, a P/E ratio of 14.59, a P/E/G ratio of 1.10 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the company earned $5.90 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.90%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.